Detection of human herpesvirus 6 in tissues involved by sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease).

After preliminary serologic data demonstrated elevated antibody titers to human herpesvirus (HHV) 6 in patients with sinus histiocytosis with massive lymphadenopathy (SHML) or Rosai-Dorfman disease, tissues were examined from 9 patients with classical SHML to search for evidence of HHV-6 infection. Involved tissues from 7 of the 9 patients had detectable HHV-6 by in situ hybridization: Tissue from 1 had detectable Epstein-Barr virus genome but no HHV-6 and tissue from another had no detectable HHV-6 or Epstein-Barr virus. These studies suggest that HHV-6 and, to a lesser extent, Epstein-Barr virus may be involved in the etiology of SHML.

[1]  E. Jaffe,et al.  In situ hybridization detection of human herpesvirus 6 in biopsy specimens from Chinese patients with non-Hodgkin's lymphoma. , 1993, Archives of pathology & laboratory medicine.

[2]  S. Ferrari,et al.  Human herpesvirus-6 in human lymphomas: identification of specific sequences in Hodgkin's lymphomas by polymerase chain reaction. , 1991, Blood.

[3]  M. Fischer,et al.  Human herpesvirus-6 infection may predispose cells to superinfection by other viruses. , 1991, In vivo.

[4]  P. Levine,et al.  Patterns of chromosomal breakpoint locations in Burkitt's lymphoma: relevance to geography and Epstein-Barr virus association. , 1991, Blood.

[5]  S. Hamilton-Dutoit,et al.  Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease , 1991, The Lancet.

[6]  T. Wu,et al.  Detection of ebv gene expression in reed‐sternberg cells of Hodgkin's disease , 1990, International journal of cancer.

[7]  D. Purtilo,et al.  Immune deficiency as a risk factor in Epstein-Barr virus-induced malignant diseases. , 1990, Environmental health perspectives.

[8]  R. Saltzman,et al.  The spectrum of clinical and laboratory findings resulting from human herpesvirus-6 (HHV-6) in patients with mononucleosis-like illnesses not resulting from Epstein-Barr virus or cytomegalovirus. , 1990, American journal of clinical pathology.

[9]  D. Onions,et al.  The seroepidemiology of human herpesvirus‐6 (HHV‐6) from a case‐control study of leukaemia and lymphoma , 1990, International journal of cancer.

[10]  J. Rosai,et al.  Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): review of the entity. , 1990, Seminars in diagnostic pathology.

[11]  Komp Dm.  The treatment of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). , 1990 .

[12]  J. Rosai,et al.  Immunophenotypic characterization of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). , 1990, Seminars in diagnostic pathology.

[13]  B. Dastugue,et al.  Detection of epstein‐barr viral genomes in lymph nodes of Hodgkin's disease patients , 1990, Molecular carcinogenesis.

[14]  F. Berthold,et al.  Persistent active herpes virus infection associated with atypical polyclonal lymphoproliferation (APL) and malignant lymphoma. , 1989, Anticancer research.

[15]  Y. Sakiyama,et al.  Human herpesvirus 6 infection and Kawasaki disease , 1989, Journal of clinical microbiology.

[16]  T. Yoshikawa,et al.  Human herpesvirus-6 infection (exanthem subitum) without rash. , 1989, Pediatrics.

[17]  R. Warnke,et al.  Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. , 1989, The New England journal of medicine.

[18]  James F. Jones,et al.  The Post-Infectious Chronic Fatigue Syndrome , 1989 .

[19]  Jaffe Es.  Histiocytoses of lymph nodes: biology and differential diagnosis. , 1988 .

[20]  P. Biberfeld,et al.  Human herpesvirus-6 (HHV-6, HBLV) in sarcoidosis and lymphoproliferative disorders. , 1988, Journal of virological methods.

[21]  K. Yamanishi,et al.  IDENTIFICATION OF HUMAN HERPESVIRUS-6 AS A CAUSAL AGENT FOR EXANTHEM SUBITUM , 1988, The Lancet.

[22]  M. Raffeld,et al.  Detection of human B-lymphotropic virus (human herpesvirus 6) sequences in B cell lymphoma tissues of three patients. , 1988, Leukemia.

[23]  A. Huang,et al.  The differentiated form of nasopharyngeal carcinoma contains epstein‐barr virus DNA , 1987, International journal of cancer.

[24]  M. Kaplan,et al.  Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. , 1986, Science.

[25]  J. Rosai,et al.  Immunologic abnormalities and their significance in sinus histiocytosis with massive lymphadenopathy. , 1984, American Journal of Clinical Pathology.

[26]  J. Rosai,et al.  Sinus histiocytosis with massive lymphadenopathy. An analysis of 14 deaths occurring in a patient registry , 1984, Cancer.

[27]  E. Jaffe,et al.  Leu M1 and peanut agglutinin stain the neoplastic cells of Hodgkin's disease. , 1984, American journal of clinical pathology.

[28]  E. Jaffe,et al.  The pathologic spectrum of adult T‐cell leukemia/lymphoma in the United States: Human T‐cell leukemia/lymphoma virus‐associated lymphoid malignancies , 1984, The American journal of surgical pathology.

[29]  R. Warnke,et al.  Lymphadenopathy simulating the malignant lymphomas. , 1974, Human pathology.

[30]  G. Klein,et al.  Patterns of antibodies to Epstein-Barr virus-induced early antigens in Burkitt's lymphoma. Comparison of dying patients with long-term survivors. , 1973, Journal of the National Cancer Institute.

[31]  J. Rosai,et al.  Sinus histiocytosis with massive lymphadenopathy: A pseudolymphomatous benign disorder.Analysis of 34 cases , 1972, Cancer.

[32]  P. Levine,et al.  Elevated antibody titers to epstein‐barr virus in Hodgkin's disease , 1971, Cancer.

[33]  G. Klein,et al.  Epstein–Barr Virus in Burkitt's Lymphoma and Nasopharyngeal Carcinoma: EBV DNA in Biopsies of Burkitt Tumours and Anaplastic Carcinomas of the Nasopharynx , 1970, Nature.

[34]  J. Rosai,et al.  Sinus histiocytosis with massive lymphadenopathy. A newly recognized benign clinicopathological entity. , 1969, Archives of pathology.

[35]  V. Diehl,et al.  Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis. , 1968, Proceedings of the National Academy of Sciences of the United States of America.

[36]  W. Henle,et al.  Immunofluorescence in Cells Derived from Burkitt's Lymphoma , 1966, Journal of bacteriology.